Advertisement
Screener

NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) Notes Payable, Current

2.8 / 5 stars · 68/120 Roast Me

NATURAL ALTERNATIVES INTERNATIONAL INC Notes Payable, Current

NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) had Notes Payable, Current of $312.00 thousand as of 2026-03-31, per its 10-Q filed 2026-05-19.

Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities

us-gaap:NotesPayableCurrent · last filed 2026-05-19

  • 2026-03-31: Notes Payable, Current $312.00K.
  • 2025-12-31: Notes Payable, Current $310.00K.
  • 2025-09-30: Notes Payable, Current $308.00K.
  • 2025-06-30: Notes Payable, Current $305.00K.
Period endNotes Payable, Current
2026-03-31$312.00K
10-Q · filed 2026-05-19
2025-12-31$310.00K
10-Q · filed 2026-02-13
2025-09-30$308.00K
10-Q · filed 2025-11-12
2025-06-30$305.00K
10-Q · filed 2026-05-19
2025-03-31$303.00K
10-Q · filed 2025-05-14
2024-12-31$301.00K
10-Q · filed 2025-02-14
2024-09-30$298.00K
10-Q · filed 2024-11-13
2024-06-30$296.00K
10-K · filed 2025-09-23
2024-03-31$294.00K
10-Q · filed 2024-05-14
2023-12-31$292.00K
10-Q · filed 2024-02-13
2023-09-30$290.00K
10-Q · filed 2023-11-09
2023-06-30$312.00K
10-K · filed 2024-09-27
2023-03-31$309.00K
10-Q · filed 2023-05-15
2022-12-31$307.00K
10-Q · filed 2023-02-08
2022-09-30$305.00K
10-Q · filed 2022-11-09
2022-06-30$302.00K
10-K · filed 2023-09-21
2022-03-31$300.00K
10-Q · filed 2022-05-13
2021-12-31$298.00K
10-Q · filed 2022-02-09
2021-09-30$296.00K
10-Q · filed 2021-11-09
2021-06-30$0.00
10-K · filed 2022-09-21

Similar stocks

Stock NameCountryMarket CapPE Ratio
MANNATECH INC (MTEX)United States$0.014B
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Canopy Growth Corp (CGC)$0.395B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87